衰弱对重症监护病房结局的影响:系统评价与荟萃分析
该系统评价与荟萃分析比较了ICU收治的衰弱与非衰弱成人患者的临床结局,共纳入10项观察性研究、3030例患者(衰弱927例,非衰弱2103例)。衰弱与院内死亡风险升高相关(RR 1.71;95%CI 1.43,2.05;P<0.00001;I²=32%),与远期死亡风险升高相关(RR 1.53;95%CI 1.40,1.68;P<0.00001;I²=0%)。衰弱合并患病率为30%(95%CI 29-32%)。衰弱患者出院回家可能性低于非衰弱患者(RR 0.59;95%CI 0.49,0.71;P<0.00001;I²=12%)。作者认为,识别这一既往未被充分认识的脆弱ICU人群应成为研究和实施适当照护计划的推动力。
要点
- ICU成人患者中衰弱合并患病率为30%(95%CI 29-32%)。
- 衰弱患者院内死亡风险高于非衰弱患者(RR 1.71;95%CI 1.43,2.05;P<0.00001;I²=32%)。
- 衰弱患者远期死亡风险高于非衰弱患者(RR 1.53;95%CI 1.40,1.68;P<0.00001;I²=0%)。
- 衰弱患者出院回家可能性低于非衰弱患者(RR 0.59;95%CI 0.49,0.71;P<0.00001;I²=12%)。
- 作者认为,识别ICU衰弱人群应成为研究和实施适当照护计划的推动力。
适用人群与场景
- 纳入研究的对象为年龄大于18岁、收治于ICU的患者,比较衰弱与健康(非衰弱)患者的结局。
- 排除叙述性综述、病例报告和社论。
研究设计与关键结果
- 研究类型为系统评价与荟萃分析,纳入10项观察性研究,共3030例患者(衰弱927例,非衰弱2103例),研究总体质量为中等。
- 主要结局:院内死亡风险衰弱组高于非衰弱组(RR 1.71;95%CI 1.43,2.05;P<0.00001;I²=32%);远期死亡风险衰弱组高于非衰弱组(RR 1.53;95%CI 1.40,1.68;P<0.00001;I²=0%)。
- 衰弱合并患病率为30%(95%CI 29-32%)。
- 出院回家可能性衰弱组低于非衰弱组(RR 0.59;95%CI 0.49,0.71;P<0.00001;I²=12%)。
证据类型、等级与局限
- 证据类型为系统评价与荟萃分析,纳入10项观察性研究,总体质量为中等。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,识别这一既往未被充分认识的脆弱ICU人群应成为研究和实施适当照护计划的推动力。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Functional status and chronic health status are important baseline characteristics of critically ill patients. The assessment of frailty on admission to the intensive care unit (ICU) may provide objective, prognostic information on baseline health. To determine the impact of frailty on the outcome of critically ill patients, we performed a systematic review and meta-analysis comparing clinical outcomes in frail and non-frail patients admitted to ICU.
METHODS: We searched the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, PubMed, CINAHL, and Clinicaltrials.gov. All study designs with the exception of narrative reviews, case reports, and editorials were included. Included studies assessed frailty in patients greater than 18 years of age admitted to an ICU and compared outcomes between fit and frail patients. Two reviewers independently applied eligibility criteria, assessed quality, and extracted data. The primary outcomes were hospital and long-term mortality. We also determined the prevalence of frailty, the impact on other patient-centered outcomes such as discharge disposition, and health service utilization such as length of stay.
RESULTS: Ten observational studies enrolling a total of 3030 patients (927 frail and 2103 fit patients) were included. The overall quality of studies was moderate. Frailty was associated with higher hospital mortality [relative risk (RR) 1.71; 95% CI 1.43, 2.05; p < 0.00001; I 2 = 32%] and long-term mortality (RR 1.53; 95% CI 1.40, 1.68; p < 0.00001; I 2 = 0%). The pooled prevalence of frailty was 30% (95% CI 29-32%). Frail patients were less likely to be discharged home than fit patients (RR 0.59; 95% CI 0.49, 0.71; p < 0.00001; I 2 = 12%).
CONCLUSIONS: Frailty is common in patients admitted to ICU and is associated with worsened outcomes. Identification of this previously unrecognized and vulnerable ICU population should act as the impetus for investigating and implementing appropriate care plans for critically ill frail patients. Registration: PROSPERO (ID: CRD42016053910).
参考来源
- Muscedere J, Waters B, Varambally A, et al. The impact of frailty on intensive care unit outcomes: a systematic review and meta-analysis. Intensive Care Med. 2017. PMID: 28676896. doi:10.1007/s00134-017-4867-0
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。